Candida glabrata fungemia -: Clinical features of 139 patients

被引:63
作者
Gumbo, T
Isada, CM
Hall, G
Karafa, MT
Gordon, SM
机构
[1] Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Biostat, Cleveland, OH 44195 USA
关键词
D O I
10.1097/00005792-199907000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Candida species are now the fourth leading cause of nosocomial bloodstream infection in hospitalized patients, and non-Candida albicans species now surpass Candida albicans. The clinical features of the most common non-Candida albicans species, Candida (Torulopsis) glabrata, have not been well studied. We retrospectively reviewed the clinical features of 139 patients with C. glabrata bloodstream infection over a period of 7 years. The mean age of patients was 62 years, and the most common admitting diagnoses were malignancy (28%) and coronary artery disease (18%). The most common identified portals of entry were abdominal (22%) and intravascular catheters (16%). At the time of fungemia, 63% of patients had fever, 45% had change in mental status, and 30% were in septic shock. Three of 50 patients examined by an ophthalmologist had chorioretinitis. The overall hospital mortality was 49%. Factors associated with increased mortality in a regression model were prior abdominal surgery (odds ratio [OR] = 2.8; 95% confidence interval [CI] = 1.2-6.3, p = 0.01), and an elevated creatinine (OR = 2.2; 95% CI = 1.0- 4.7, p = 0.05). When early deaths (≤72 hours) were censored, amphotericin B treatment and total dose were associated with reduced mortality (OR = 0.2; 95% CI = 0.1-0.4, p ≤ 0.001). Nosocomial C. glabrata fungemia is not just a disease of debilitated and neutropenic patients, but affects a wide variety of patients and is associated with a high mortality.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 27 条
  • [1] The epidemiology of hematogenous candidiasis caused by different Candida species
    AbiSaid, D
    Anaissie, E
    Uzun, O
    Raad, I
    Pinzcowski, H
    Vartivarian, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) : 1122 - 1128
  • [2] Yeast-like fungi of the human intestinal tract
    Anderson, HW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1917, 21 (04) : 341 - U18
  • [3] BANERJEE SN, 1991, AM J MED S3B, V91, P86
  • [4] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [5] Yeastlike fungi found on the skin and in the intestines of normal subjects - A survey of one hundred persons
    Benham, RW
    Hopkins, AM
    [J]. ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1933, 28 (04): : 532 - 543
  • [6] TORULOPSIS GLABRATA FUNGEMIA - CLINICAL PATHOLOGICAL-STUDY
    BERKOWITZ, ID
    ROBBOY, SJ
    KARCHMER, AW
    KUNZ, LJ
    [J]. MEDICINE, 1979, 58 (06) : 430 - 440
  • [7] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [8] CANDIDEMIA IN A TERTIARY CARE HOSPITAL - EPIDEMIOLOGY, RISK-FACTORS, AND PREDICTORS OF MORTALITY
    FRASER, VJ
    JONES, M
    DUNKEL, J
    STORFER, S
    MEDOFF, G
    DUNAGAN, WC
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) : 414 - 421
  • [9] Can we agree on the treatment of candidiasis? Response
    Graybill, JR
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) : 60 - 62
  • [10] EPIDEMIOLOGY OF NOSOCOMIAL FUNGAL-INFECTIONS, WITH EMPHASIS ON CANDIDA SPECIES
    JARVIS, WR
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (06) : 1526 - 1530